WELLINGTON, Fla., March 13, 2017 -- KLX Inc. (NASDAQ:KLXI), a leading distributor and value added service provider of aerospace fasteners and consumables, and a provider of services and products to the oil and gas industry, announced today that its Board of Directors has authorized an increase in the Company’s share repurchase authorization from $100 million to $200 million. To date, KLX has repurchased approximately $60 million of shares under the original authorization. This increased authorization allows for an additional $140 million of future share repurchases.
Repurchases will be made in open market or privately negotiated transactions in compliance with Securities and Exchange Rule 10b-18, subject to market conditions, applicable legal requirements, and other relevant factors. The share repurchase program does not obligate KLX to acquire any particular amount of common stock, and it may be suspended at any time at KLX’s discretion.
About KLX Inc.
KLX Inc., through its two operating segments, provides mission critical products and complex logistical solutions to support its customers’ high value assets. KLX serves its customers in demanding environments that face high cost of downtime and require dependable, high quality just-in-time customer support. The Aerospace Solutions Group is a leading distributor and value added service provider of aerospace fasteners and consumables offering the broadest range of aerospace hardware and consumables and inventory management services worldwide. The Energy Services Group provides vital services and products to the oil and gas industry on an episodic, 24/7 basis. For more information, visit the KLX website at www.klx.com.
CONTACT: Michael Perlman Assistant Treasurer KLX Inc. (561) 383-5100


Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 



